Clinical Trials Browser

Phase 3 × HIV Infections × Doxorubicin × Clear all

NCT00000658 2021-11-03

A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma

Phase 3 Completed

Acquired Immunodeficiency Syndrome, Lymphoma, Non-Hodgkin, HIV Infections

NCT00002093 2005-06-24

A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.

Phase 3 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00002105 2005-06-24

Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma

Phase 3 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00002147 2005-06-24

Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.

Phase 3 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00002318 2005-06-24

A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma

Phase 3 Unknown

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00002319 2005-06-24

A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma

Phase 3 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections